ShockWave Medical stock is trading -35.77% below its average target price of $270.82 after dropping -2.4% during today's morning session. Analysts are giving the mid-cap Medical Instruments & Supplies company an average rating of buy and target prices ranging from $165.0 to $330.0 per share.
ShockWave Medical has an average level of shares sold short, at 6.0% of its total share float. The stock's short ratio (also called days to cover) is 3.39. Since 1.18% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests.
Institutional investors own 93.3% of ShockWave Medical's shares, which indicates they have a high level of confidence in the company.
Institutions Invested in ShockWave Medical
Date Reported | Holder | Percentage | Shares | Value |
---|---|---|---|---|
2023-06-30 | Blackrock Inc. | 10% | 3,636,444 | $632,574,348 |
2023-06-30 | Vanguard Group Inc | 10% | 3,603,014 | $626,759,063 |
2023-06-30 | FMR, LLC | 7% | 2,434,974 | $423,573,714 |
2023-06-30 | Wellington Management Group, LLP | 4% | 1,352,723 | $235,311,714 |
2023-06-30 | Artisan Partners Limited Partnership | 3% | 1,147,784 | $199,661,734 |
2023-06-30 | Price (T.Rowe) Associates Inc | 3% | 1,091,050 | $189,792,622 |
2023-06-30 | State Street Corporation | 3% | 1,018,186 | $177,117,630 |
2023-06-30 | JP Morgan Chase & Company | 2% | 835,138 | $145,275,680 |
2023-06-30 | Invesco Ltd. | 2% | 773,776 | $134,601,508 |
2023-09-30 | Allspring Global Investments Holdings, LLC | 2% | 645,634 | $112,310,682 |